Desmoglein 3 is a critical cadherin family cell adhesion molecule that plays a pivotal role in the formation and maintenance of desmosomes, which are specialized structures essential for cell-cell adhesion in epithelial tissues. As a component of the desmosomal complex, desmoglein 3 contributes to the structural integrity and mechanical stability of tissues, particularly in areas subjected to significant stress and friction, such as the skin and mucous membranes. This protein facilitates the adhesive connections that bind cells tightly together, ensuring tissue cohesion and resistance to mechanical stress. Beyond its structural roles, desmoglein 3 is involved in signaling pathways that regulate cell proliferation, differentiation, and apoptosis, underscoring its importance not only in tissue architecture but also in cellular homeostasis and the maintenance of epithelial barrier function.
The activation of desmoglein 3 involves a complex interplay of intracellular and extracellular signals that enhance its adhesive function and integration into the desmosomal complex. At the transcriptional level, the expression of desmoglein 3 is regulated by various signaling pathways responsive to cellular context and environmental cues, ensuring its availability for desmosome assembly and function. Post-translational modifications, including phosphorylation and glycosylation, play crucial roles in modulating the adhesive properties of desmoglein 3, affecting its conformation and the strength of cell-cell adhesion. Furthermore, the assembly of desmoglein 3 into the desmosome involves interactions with other desmosomal proteins, such as desmocollins and plakoglobin, which are mediated by the cytoplasmic domain of desmoglein 3. This assembly process is finely tuned by signaling pathways that govern cellular adhesion dynamics, allowing for the adaptation of tissue architecture to changing physiological conditions. Activation of desmoglein 3, therefore, not only reinforces structural integrity and cohesion within epithelial tissues but also participates in the broader context of cellular signaling, contributing to the regulation of epithelial tissue function and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin is a hormone that, among other functions, activates the PI3K/Akt pathway. Activation of the PI3K/Akt pathway can lead to an increase in the phosphorylation status of desmoglein 3, thereby enhancing its stability and function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a chemical that activates adenylyl cyclase, leading to increased levels of cyclic AMP (cAMP). cAMP can activate protein kinase A (PKA), which can increase the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a chemical that activates the JNK pathway. Activation of the JNK pathway can lead to an increase in the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC can lead to increased phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA is a bioactive lipid that activates the LPA receptors. Activation of the LPA receptors can lead to the activation of downstream pathways, including the PI3K/Akt pathway, which can increase the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a PPARγ agonist. Activation of PPARγ can modulate the PI3K/Akt pathway, which can increase the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a bioactive lipid that activates the S1P receptors. Activation of the S1P receptors can lead to the activation of downstream pathways, including the PI3K/Akt pathway, which can increase the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
Diacylglycerol (DAG) is a lipid that activates protein kinase C (PKC). Activation of PKC can lead to increased phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin is a peptide that activates the bradykinin receptors. Activation of the bradykinin receptors can lead to the activation of downstream pathways, including the PI3K/Akt pathway, which can increase the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II is a peptide hormone that activates the angiotensin II type 1 receptor (AT1R). Activation of AT1R can lead to the activation of downstream pathways, including the PI3K/Akt pathway, which can increase the phosphorylation of desmoglein 3, thereby enhancing its stability and function. | ||||||